"Heparin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts.
| Descriptor ID |
D006493
|
| MeSH Number(s) |
D09.698.373.400
|
| Concept/Terms |
Heparin- Heparin
- Unfractionated Heparin
- Heparin, Unfractionated
- Heparinic Acid
|
Below are MeSH descriptors whose meaning is more general than "Heparin".
Below are MeSH descriptors whose meaning is more specific than "Heparin".
This graph shows the total number of publications written about "Heparin" by people in this website by year, and whether "Heparin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 1 | 2 |
| 1996 | 0 | 1 | 1 |
| 1997 | 2 | 1 | 3 |
| 1998 | 2 | 0 | 2 |
| 1999 | 2 | 2 | 4 |
| 2000 | 2 | 2 | 4 |
| 2001 | 4 | 6 | 10 |
| 2002 | 0 | 3 | 3 |
| 2003 | 6 | 0 | 6 |
| 2004 | 6 | 3 | 9 |
| 2005 | 3 | 2 | 5 |
| 2006 | 0 | 1 | 1 |
| 2007 | 2 | 2 | 4 |
| 2008 | 2 | 4 | 6 |
| 2009 | 4 | 2 | 6 |
| 2010 | 2 | 2 | 4 |
| 2011 | 2 | 3 | 5 |
| 2012 | 6 | 1 | 7 |
| 2013 | 7 | 0 | 7 |
| 2014 | 5 | 3 | 8 |
| 2015 | 4 | 1 | 5 |
| 2016 | 3 | 1 | 4 |
| 2017 | 5 | 4 | 9 |
| 2018 | 1 | 2 | 3 |
| 2019 | 2 | 3 | 5 |
| 2020 | 1 | 3 | 4 |
| 2021 | 0 | 2 | 2 |
| 2022 | 3 | 6 | 9 |
| 2023 | 1 | 3 | 4 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Heparin" by people in Profiles.
-
Bivalirudin: The misunderstood alternative to heparin. Paediatr Anaesth. 2024 05; 34(5):394-395.
-
Thromboelastography versus thromboelastometry for unfractionated heparin monitoring in adult patients on extracorporeal membrane oxygenation. Perfusion. 2025 Jan; 40(1):235-242.
-
Systemic anticoagulation in ECMO. Semin Pediatr Surg. 2023 Aug; 32(4):151333.
-
A MALDI Mass Spectrometry Imaging Sample Preparation Method for Venous Thrombosis with Initial Lipid Characterization of Lab-Made and Murine Clots. J Am Soc Mass Spectrom. 2023 Sep 06; 34(9):1879-1889.
-
Safety of routine protamine in the reversal of heparin in percutaneous coronary intervention: A systematic review and meta-analysis. Int J Cardiol. 2023 10 01; 388:131168.
-
Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates. Clin Cancer Res. 2023 07 05; 29(13):2525-2539.
-
Rate of venous thromboembolism on an enhanced recovery program after gynecologic surgery. Am J Obstet Gynecol. 2023 08; 229(2):140.e1-140.e7.
-
Evaluation of acquired antithrombin deficiency in paediatric patients supported on extracorporeal membrane oxygenation. Br J Clin Pharmacol. 2023 08; 89(8):2396-2406.
-
The History of Extracorporeal Membrane Oxygenation and the Development of Extracorporeal Membrane Oxygenation Anticoagulation. Semin Thromb Hemost. 2024 Feb; 50(1):81-90.
-
Enoxaparin may be associated with lower rates of mortality than unfractionated heparin in neurocritical and surgical patients. J Thromb Thrombolysis. 2023 Apr; 55(3):439-448.